Q-omics provides the consensus-scored MIR5002 profile across patient tissues and cancer cell-line models. MIR5002 expression is associated with patient survival in 14 of 34 cancer types, with the highest sampling consensus in MESO. Additionally, MIR5002 RNA expression shows 10,792 significant protein co-abundance associations, with the highest sampling consensus in CCRCC. Together, these results highlight MESO, and CCRCC as cancer lineages where MIR5002 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.